Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
32,782,327
-
Share change
-
+2,453,997
-
Total reported value
-
$112,437,236
-
Put/Call ratio
-
0%
-
Price per share
-
$3.43
-
Number of holders
-
121
-
Value change
-
+$8,596,769
-
Number of buys
-
64
-
Number of sells
-
48
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2025
As of 30 Jun 2025,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,782,327 shares.
The largest 10 holders included
ACORN CAPITAL ADVISORS, LLC, BlackRock, Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, AMERICAN CENTURY COMPANIES INC, DIMENSIONAL FUND ADVISORS LP, KENNEDY CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
121
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.